©2008 The WJG Press and Baishideng.
World J Gastroenterol. Dec 28, 2008; 14(48): 7289-7301
Published online Dec 28, 2008. doi: 10.3748/wjg.14.7289
Published online Dec 28, 2008. doi: 10.3748/wjg.14.7289
Table 1 Management of acute radiation colitis
| Management of acute radiation colitis |
| Supportive management |
| Anti-diarrheal medications and by reducing fat and lactose intake; |
| In intractable cases hospitalization is required for parenteral feeding and elementary diet |
| Elk-1 inhibitors |
| Compound A (CpdA) |
| U0126 [1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio) butadiene] |
| Modulation of leukocyte recruitment and activation pathway |
| Targeting P-selectin and/or lymphocyte function antigen-1 |
| Cu/Zn-SOD1 supplementation |
| Synthetic somatostatin analog octreotide |
| Other measures |
| Antiemetics |
| Steroid-containing suppositories |
| Recombinant granulocyte colony-stimulating factor in neutropenia |
| Epidermal growth factor |
- Citation: Kountouras J, Zavos C. Recent advances in the management of radiation colitis. World J Gastroenterol 2008; 14(48): 7289-7301
- URL: https://www.wjgnet.com/1007-9327/full/v14/i48/7289.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.7289